Federal health officials appear before House committee to discuss coronavirus
Health leaders set the record straight on testing and outbreaks in recently reopened states.
Regulatory
Appeals court strikes down the rule requiring list prices in drug ads, again
A previous judge ruled that HHS did not have the authority to issue the rule.
FDA app allows doctors to share real-world COVID-19 information
The CureID app is also collaborating with the WHO and the Infectious Disease Society of America.
FDA cracks down on online retailers selling scam COVID-19 treatments
The Food and Drug Administration has issued warning letters in recent weeks to websites selling scam COVID-19 treatments.
FDA partners with Aetion to gather real-world data on the coronavirus
The FDA continues its investment in real-world data with this partnership.
Pricing remdesivir: Will Gilead profit from the COVID-19 treatment?
As remdesivir emerges as an effective coronavirus treatment, how Gilead prices the drug will face heightened scrutiny.
A look at emergency use authorizations during COVID-19
Four treatments have been granted the emergency use authorization.
Telehealth rules relaxed, but patients still face barriers
The government has relaxed telehealth rules as most people stay home to help flatten the curve, but patients still face barriers for virtual visits.
FDA drug reviews chug along during coronavirus, but for how long?
The FDA said drug and device reviews are continuing at the normal rate, but warned that may not be able to continue indefinitely as the pandemic drags on.
Government, researchers and big tech team up for digital COVID-19 tools
Apple, Facebook and Verily are working on digital tools to help track infections and inform the public about the virus.
Want to read more?
Please login or register first to view this content.
